Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Oesophageal Cancer: Conformal Radiotherapy vs. Hybrid-VMAT Technique With Two Different Treatment Planning Systems

MASAYOSHI MIYAZAKI, SHINGO OHIRA, YOSHIHIRO UEDA, MASARU ISONO, MASAYUKI FUJIWARA, MASAO TANOOKA, WATARU OKADA, RYUTA NAKAHARA, MASAKI SUEOKA, HITOMI SUZUKI, TERUKI TESHIMA and KOICHIRO YAMAKADO
In Vivo January 2020, 34 (1) 331-337; DOI: https://doi.org/10.21873/invivo.11778
MASAYOSHI MIYAZAKI
1Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
2Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: masayoshi.miyazaki{at}gmail.com
SHINGO OHIRA
2Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
3Department of Radiation Oncology, Osaka University Graduate School of Medicine, Suita, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIHIRO UEDA
2Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
3Department of Radiation Oncology, Osaka University Graduate School of Medicine, Suita, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASARU ISONO
2Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAYUKI FUJIWARA
1Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAO TANOOKA
1Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WATARU OKADA
1Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RYUTA NAKAHARA
1Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAKI SUEOKA
1Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HITOMI SUZUKI
1Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TERUKI TESHIMA
2Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOICHIRO YAMAKADO
1Department of Radiology, Hyogo College of Medicine, Hyogo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Axial (upper) and coronal (lower) dose distribution of >5 Gy for the three planning techniques for one patient. (A) CRT plan, (B) h-VMAT plan using Eclipse, (C) h-VMAT plan using RayStation. The color of dose distribution is >5 Gy (blue), >20 Gy (light blue), >30 Gy (green), >45 Gy (yellow), >55 Gy (orange).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Example of DR for h-VMAT plan between Eclipse (blue) and RayStation (red).

Tables

  • Figures
  • Table I.
  • Table II.
PreviousNext
Back to top

In this issue

In Vivo
Vol. 34, Issue 1
January-February 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Oesophageal Cancer: Conformal Radiotherapy vs. Hybrid-VMAT Technique With Two Different Treatment Planning Systems
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Oesophageal Cancer: Conformal Radiotherapy vs. Hybrid-VMAT Technique With Two Different Treatment Planning Systems
MASAYOSHI MIYAZAKI, SHINGO OHIRA, YOSHIHIRO UEDA, MASARU ISONO, MASAYUKI FUJIWARA, MASAO TANOOKA, WATARU OKADA, RYUTA NAKAHARA, MASAKI SUEOKA, HITOMI SUZUKI, TERUKI TESHIMA, KOICHIRO YAMAKADO
In Vivo Jan 2020, 34 (1) 331-337; DOI: 10.21873/invivo.11778

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Oesophageal Cancer: Conformal Radiotherapy vs. Hybrid-VMAT Technique With Two Different Treatment Planning Systems
MASAYOSHI MIYAZAKI, SHINGO OHIRA, YOSHIHIRO UEDA, MASARU ISONO, MASAYUKI FUJIWARA, MASAO TANOOKA, WATARU OKADA, RYUTA NAKAHARA, MASAKI SUEOKA, HITOMI SUZUKI, TERUKI TESHIMA, KOICHIRO YAMAKADO
In Vivo Jan 2020, 34 (1) 331-337; DOI: 10.21873/invivo.11778
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledegments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Dosimetric Comparison of Radiation Therapy Using Hybrid-VMAT Technique for Stage I Esophageal Cancer
  • Google Scholar

More in this TOC Section

  • Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS
  • Expression Patterns of T-cell immunoreceptor With Ig and ITIM domains (TIGIT) in Classical Hodgkin Lymphoma: A Clinicopathological Study
  • Older Age and Outcomes of Intravesical Bacillus Calmette-Guérin for Non-muscle-invasive Bladder Cancer
Show more Clinical Studies

Keywords

  • Hybrid-VMAT
  • treatment planning
  • plan evaluation
  • oesophageal cancer
In Vivo

© 2026 In Vivo

Powered by HighWire